News
Should you invest $1,000 in Hims & Hers Health right now? Before you buy stock in Hims & Hers Health, consider this: The ...
Hims & Hers Health has seen massive success, aided by the growing use of GLP-1 drugs. Click here to find out why I downgrade ...
Hims agreed to buy private European telehealth firm Zava, which operates in the U.K., Germany, France, and Ireland.
Hims & Hers is acquiring digital health provider ZAVA to expand into Europe, aiming to boost revenue and international market ...
Hims & Hers Health has a better P/E ratio of 77.6 than the aggregate P/E ratio of 48.44 of the Health Care Providers & ...
Hims & Hers expanding in Europe with the purchase of London-based digital health platform ZAVA. The acquisition gives the ...
The cash-based acquisition – the financial terms of which are not being disclosed – will expand Hims & Hers' presence in the ...
Hims & Hers (HIMS) doubles revenue, expands margins, and grows subscribers. Zava acquisition triples market potential, ...
Hims & Hers Health will acquire Zava, expanding the company’s services to Ireland, France and Germany and growing its active ...
Hims & Hers Health (HIMS) announced it will be acquiring European telehealth platform Zava in an all-cash deal. The stock is ...
HIMS showcases outstanding financial strength. With just $63 million in debt against a market value of $13 billion, the ...
Tuesday, online health and wellness company Hims & Hers announced its intent to acquire European digital healthcare provider ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results